summARY The relation of cigarette smoking to both coronary disease and non-fatal myocardial infarction was examined in a cross sectional study of 1053 women who underwent coronary arteriography. As compared with the 489 women who had never smoked cigarettes, ever-smokers (mean duration ofsmoking, 25 years) were 1-6 times as likely to have significant stenotic disease and were 1 9 times as likely to have suffered a myocardial infarction. These associations were strongest in women under 50 years of age, with odds ratios of 3-5 for coronary artery disease and 4-5 for myocardial infarction. Although the extent ofstenotic disease and prior myocardial infarction were strongly associated, women who smoked cigarettes remained at increased risk of a myocardial infarction even after their increased coronary artery disease had been taken into account. For example, heavy smokers (>30 pack-years) were 2-3 times as likely to have had a myocardial infarction as were non-smokers; controlling for the extent of stenotic disease (in addition to age and other risk factors) reduced the estimated relative risk to only 1-9. Stratified analyses showed that this increased risk for clinical disease among smokers was evident at all levels of occlusion, even among women with minimal stenotic disease. These results, collected at the time of arteriography, suggest that non-atherogenic mechanisms may be important in the aetiology of myocardial infarction among women who smoke cigarettes.
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Cigarette smoking is widely recognised as an important risk factor for coronary heart disease in men, with the risk of myocardial infarction and sudden death increasing with the number of cigarettes smoked daily."2 Recent case-control34 and cohort' studies have also reported an increased risk of coronary heart disease among female smokers. In general, women who smoke cigarettes are two to four times as likely to develop clinical disease as are nonsmokers, with younger women and those smoking Freedman, Gruchow, Walker, Jacobsen, Anderson, Sobocinski, Barboriak Because it gives information on both coronary artery disease and previous non-fatal myocardial infarction, coronary arteriography provides a unique opportunity to assess the importance of occlusive disease and non-atherogenic factors in the development of coronary heart disease."6 For example, we have shown that even after controlling for the extent of coronary occlusion, "heavy" cigarette smoking doubles the risk for non-fatal myocardial infarction among men,'7 suggesting that smoking may be involved in the precipitation of a myocardial infarction rather than in the development of atherosclerosis. Previous arteriography studies examining the relation of cigarette smoking to coronary artery disease have yielded conflicting results, ranging from a strong, positive association'8 to a non-significant, negative relation. '9 Because smoking may account for over a half of all coronary heart disease in women below the age of 55, 3 7 it is important to elucidate the possible mechanism(s) of this association. Therefore, the current study uses data collected at the time of arteriography to examine the relation of cigarette smoking to nonfatal myocardial infarction. The object was to determine whether the increased risk ofmyocardial infarction among female cigarette smokers is attributable to increased stenotic disease. The cigarette smoking category (current/past/never) of 1053 women could be determined through questionnaire. Past (n = 374) and current (n = 190) smokers showed similar levels of(a) most risk factors, (b) coronary artery disease, and (c) the prevalence of prior myocardial infarction. Because many of the exsmokers were likely to have stopped smoking after a myocardial infarction (the year of stopping was not known), most analyses contrasted ever-smokers with never-smokers. (Certain analyses, however, separated the ever-smokers into past and current smokers.) Data on the duration (years) of cigarette smoking and the approximate number of cigarettes smoked daily ( < 5, 10, 20, 30, We then examined the independent relation of cigarette smoking to myocardial infarction by controlling for the extent of coronary artery disease. The occlusion score was categorised into five groups, and the association between smoking and myocardial infarction was examined within each stratum. Results were summarised over the strata using Mantel-Haenszel odds ratios, and the Mantel extension was used to test for a trend.'0
The relation of pack-years (number of packs smoked per day x duration of smoking) to myocardial infarction was then assessed by logistic regression. Predictor variables in the various models included: (a) pack-years only; (b) pack-years and the occlusion score; and (c) pack-years, occlusion, and other risk factors. (The extent of coronary artery disease was treated as a risk factor for myocardial 275 infarction in these last two models.) To avoid assumptions about the shape of the association between pack-years and myocardial infarction,3' dummy variables (representing categories of pack-years) were used in these analyses.'2 Logistic regression models were also used to assess possible differences in the relation of cigarette smoking to myocardial infarction between past and current smokers.
Results
Mean values of several characteristics were first examined according to reported smoking state (never/past/current) before arteriography (data not shown). Despite a higher prevalence of hypertension among women who had never smoked, non-fatal myocardial infarctions were more common among both ex-smokers and current smokers, with estimated relative risks of 2 1 and 1 6, respectively. In addition, mean occlusion scores were approximately 25 points higher among both ex-smokers and current smokers than among women who had never smoked. Current (but not past) smokers also had slightly lower values ofbody mass index than did women who had never smoked (25 1 v 26X2 kg/m2) and both current and past smokers had raised concentrations of triglycerides (1.81 and 1-90 v 1-67 mmol/l) (161 and 168 v 148 mg/dl) and alcohol intake (69 and 1 18 v 44 ml/week). Because past and current smokers showed similar (a) risk factor values, (b) amounts of coronary artery disease, and (c) risk of previous myocardial infarction, most analyses contrasted ever-smokers (n = 564) with never-smokers (n = 489).
We then examined differences in risk factor values according to non-fatal myocardial infarction and clinically important occlusive disease (table 1). The two variables were strongly related: the mean occlusion score was approximately twice as large (1 17 v 58) among women who reported a myocardial infarction as in other patients. In general, however, risk factors were more strongly related to coronary artery disease. For example, concentrations of total cholesterol were 07 mmol/l (27 mg/dl) higher in women with occlusive disease than in those with no diseased vessels, but the difference between those with and those without a history of myocardial infarction was only 0-2 mmol/l (6 mg/dl). Smoking state (ever v never), triglyceride concentrations, hypertension, and diabetes were the only characteristics significantly related to both coronary artery disease and myocardial infarction.
Women who had smoked cigarettes had a higher mean occlusion score than non-smokers (91 for exsmokers, 79 for current smokers, 65 for neversmokers) and were 1 6 (current) to 2 1 (past) times as Table 3 shows the relation of cigarette smoking to myocardial infarction after controlling for the extent of coronary artery disease by stratification. Although many ofthe cells contain small numbers, 13 ofthe 15 odds ratios for daily cigarette consumption were > 1 and 11 of the odds ratios for smoking duration were >1. Even among women with minimal stenotic disease (occlusion score < 50), the risk of myocardial infarction was increased almost twofold among women who smoked > 1 pack daily. MantelHaenszel summary odds ratios showed that after controlling for occlusive disease, cigarette smoking remained significantly associated with myocardial infarction. Furthermore, most adjusted odds ratios were very similar to estimates that did not take the extent of coronary artery disease into account. We assessed the relative importance of smoking duration and daily consumption of cigarettes among ever-smokers (table 4) . Among these women, the estimated risk of myocardial infarction tended to be more strongly related to daily consumption (with odds ratios increasing from 1 6 to 2 4) than to duration (1-1 to 1 5). Because a small independent effect of duration on myocardial infarction risk was seen, however, daily consumption and duration were combined to form pack-years in subsequent analyses. Table 5 shows the relation of pack-years to myocardial infarction in three logistic regression models. Model 1, which contains only indicator variables that represent the three categories of pack-years, shows that the estimated risk of myocardial infarction among smokers increased from 1 5 to 2 3 with increasing number of pack-years. Furthermore, with the exception of women who had been smoking for > 30 pack-years, these associations were unaffected by controlling for the extent of stenotic disease (model 2). (Including the extent of stenotic disease as an independent variable, however, greatly improved the prediction of myocardial infarction.) Furthermore, the effect of cigarette smoking was also independent ofother risk factors (model 3). The joint contribution of eight additional risk factors in predicting myocardial infarction was only marginally significant (p = 0 11). Additional regression models that included indicator variables representing (a) past v never smokers, and (b) current v never smokers, were then constructed to assess possible differences among ever-smokers (data not shown). Results indicated that controlling for the extent of coronary artery occlusion reduced the unadjusted odds ratios from 2 1 to 1 9 among ex-smokers and did not alter the odds ratio of 1 6 among current smokers.
Discussion
The relative risk of cardiovascular disease among cigarette smokers compared with non-smokers varies according to the clinical entity examined: relative risks range from 1 for angina pectoris to > 10 for sudden death.6 In addition, the excess risk ofmyocardial infarction among cigarette smokers drops by 50o% within the first year after stopping smoking," and despite high rates of clinical disease, cigarette smokers have not consistently been found to have increased amounts of coronary atherosclerosis. '4 Therefore, smoking may be an acute precipitant for In addition to the non-representativeness of women in the current study, however, other methodological questions should be considered in interpreting these results. Because it is cross-sectional, risk factor values may not accurately reflect values in the past, and it is possible that many of the exsmokers stopped smoking shortly before arteriography, perhaps after a myocardial infarction. (This possibility is supported by the slightly higher risk associated with past, as opposed to current, smoking state.) To minimise this misclassification, however, past and current smokers were combined in most analyses in the current study; 90% of these eversmokers had smoked for > 7 years. In addition, the current analyses studied survivors of a myocardial infarction, and it is possible that the effects of cigarette smoking on sudden death may differ from those seen for non-fatal myocardial infarction. Inaccurate responses were also probably recorded for previous myocardial infarction. Although population surveys indicate that false positive responses in men may exceed 20%,' 8' women who underwent coronary arteriography in the current study were likely to have been more familiar with their medical diagnoses. For example, as previously observed in the Milwaukee Cardiovascular Data Registry, only 7% of self-reported heart attacks among 465 men could not be confirmed by data in their medical records.'7 Furthermore, women who reported a myocardial infarction in the current study had higher triglyceride concentrations and more extensive stenotic disease than did other women; occlusion scores were 117 and 58, respectively. Because smokers are (a) less likely to survive an initial myocardial infarction,353 and (b) patients who had suffered a myocardial infarction might under-report their smoking habits, the importance of cigarette smoking may have been underestimated in this study.
A myocardial infarction is typically caused by a thrombosis superimposed on a stenosed vessel, and therefore, risk ractors for coronary heart disease may act either by increasing the extent of coronary artherosclerosis or by precipitating the terminal event. There are numerous mechanisms whereby smoking could influence the risk of myocardial infarction independently of occlusive disease,34 and even without increased coronary artery disease, the frequency and duration of ischaemic episodes seem to be greatly increased among smokers.37 Cigarette smokers have raised white blood cell counts, and much evidence indicates that this is a strong predictor of myocardial infarction, possibly because raised counts can obstruct small vessels or injure endothelial cells."1 Smoking also affects haemostatic and clotting factors,'M and the relation of smoking to subsequent myocardial infarction is partly mediated by increased concentrations of fibrinogen among smokers.'4 Other mechanisms, including the toxic effects of carbon monoxide and nicotine'2 or alterations in vessel diameter9" may be involved in the pathogenesis of myocardial infarction among cigarette smokers.
Although the specific mechanisms have not been documented, the current findings show the importance of the non-atherogenic effects of cigarette smoking in the development ofmyocardial infarction among women. Irrespective of the extent ofcoronary artery disease, cigarette smokers are at increased risk for a myocardial infarction, and other findings suggest that they could quickly reduce their excess risk by stopping smoking.33 Unfortunately, the smokers at highest risk are not stopping their habit at the same rate as are those at less risk.4' Even among women who undergo arteriography, a large proportion continue to smoke.
